Omnispirant Limited
ActiveOmniSpirant develops regenerative gene therapies with game changing innovation in respiratory medicine and oncology.
What it does
"Omnispirant Limited is a pioneering biotechnology company specializing in regenerative gene therapies for respiratory medicine and oncology. Utilizing their proprietary platform, OmniSomes, Omnispirant develops innovative therapies for untreatable respiratory diseases and cancer. By leveraging inhaled bioengineered stem cell exosomes, OmniSomes efficiently deliver RNA and protein-based therapeutic agents, overcoming challenges in pulmonary gene therapy. Their groundbreaking approach targets conditions like cystic fibrosis and lung cancer, offering potential anti-inflammatory and regenerative effects. Omnispirant's advancements are poised to revolutionize respiratory medicine, improving patient outcomes and contributing to the evolution of medical treatments in the long term."
Its site says now · captured 2026-08-23
Exosome Gene Therapy - Omnispirant
OmniSpirant develop inhaled regenerative gene therapy for cystic fibrosis and other lung diseases such as COPD based on the proprietary engineered stem cell exosome platform technology
Next to it in Healthcare and bio · regenerative gene therapy for respiratory disease
- Uncommon TherapeuticsY Combinator W25
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
- AGED DiagnosticsPlug and Play PnP 2025
AGED (Active Genomes Expressed) Diagnostics is developing accurate, non-invasive blood tests for early liver disease detection.
- AmplicorePlug and Play PnP 2025
Amplicore develops regenerative injectable therapeutics for musculoskeletal disorders, aiming to restore mobility and reduce pain.
- NanograbY Combinator S23
Deliver genes to any cell with AI
- Modulari-TY Combinator W23
We teach your immune system to attack and cure cancer
- 株式会社センノ・セラピューティクスPlug and Play PnP 2026
ヒトiPS細胞由来の肝前駆細胞を活用した急性肝不全に対する細胞治療の開発
- Amplified SciencesPlug and Play PnP 2025
Amplified Sciences is a life science diagnostics company focusing on detecting and pre-empting the risks of debilitating diseases.
- GeniPhysPlug and Play PnP 2025
GeniPhys is developing and commercializing its patented Collymer™ technology platform: a first-in-class polymerizable (scaffold-forming) collagen that supports custom design and fabrication of collagen materials for accelerated and improved tissue restoration and regeneration.